Business Services
Pharmaceutical Business Services – News, analysis and company profiles
FDA orphan drug designation for treatment of rare blood cancer
February 3, 2022 Business Services
The FDA has granted orphan drug designation (ODD) to tamibarotene for the treatment of myelodysplastic syndrome (MDS). The Office of …
Vaginal HRT tablets to become available over the counter
February 3, 2022 Business Services
Vaginal oestrogen tablets, a type of hormone replacement therapy (HRT) – could become available in chemists soon, depending on the …
Illumina to advance precision medicine approach for late-stage cancer patients
February 3, 2022 Business Services
Illumina announced an agreement with the Jean Perrin Center at the Clermont-Ferrand University in France, to assess the clinical value …
CMA fines firms £35m for illegal arrangement
February 3, 2022 Business Services
The Competition and Markets Authority (CMA) has fined firms over £35 million for an illegal arrangement in the supply of …
Oncology history: Immunocore claims first-ever FDA approval of melanoma drug
January 27, 2022 Business Services
Immunocore has claimed a piece of history in biotech industry, becoming the first company to secure an FDA approval for …
Gilead combo therapy hit with FDA hold over serious adverse events
January 27, 2022 Business Services
The FDA has placed a partial clinical hold on studies conducted by Gilead Sciences assessing the combination of magrolimab plus …
Face mask rules and COVID-19 passes end in England, care home restrictions ease
January 27, 2022 Business Services
The government has announced that there will be no limit on the number of visitors to care homes in England. …
Medidata partners with Circuit Clinical to strengthen clinical trial capabilities
January 27, 2022 Business Services
Medidata has announced a partnership with Circuit Clinical to strengthen its decentralised clinical trial (DCT) capabilities. Circuit Clinical has created …
LUMAKRAS (sotorasib) receives approval in Japan for lung cancer patients
January 20, 2022 Business Services
Amgen has announced that LUMAKRAS received approval in Japan for the treatment of patients with KRAS G12C-mutated advanced non-small cell …
All Plan B restrictions to end in England
January 20, 2022 Business Services
Prime Minister Boris Johnson has announced that England’s Plan B measures are to end from 26 January. This will include …
1.27 million deaths a year attributable to antimicrobial resistance
January 20, 2022 Business Services
The Global Research on Antimicrobial Resistance (GRAM) paper has revealed the true scale of antibiotic resistance in Western Europe, and …
Vaccine alliance Gavi says that additional $5.2bn needed to ensure supply
January 20, 2022 Business Services
The chairman of the Gavi vaccine alliance, Jose Manuel Barroso, has said that an additional $5.2 billion is required to …
Benevolent AI and AstraZeneca expand collaboration on heart failure and systemic lupus discovery
January 13, 2022 Business Services
Leading clinical stage AI drug discovery company, Benevolent AI, has expanded its AI-driven drug discovery collaboration with AstraZeneca. This means …
Abivax receive EMA scientific advice support for ulcerative colitis trial
January 13, 2022 Business Services
Abivax have received scientific advice from the EMA supporting advancing ABX464 into Phase III clinical testing, for the treatment of …
Antifungal Cresemba (isavuconazole) approved for aspergillosis patients in China
January 13, 2022 Business Services
Basilea Pharmaceutica, announced that its license partner, Pfizer, has received a Drug Approval License from the National Medical Products Administration …
Latest content
Pharma sees climate disruption as growing supply-chain risk
September 11, 2026
Manchester NHS-MHRA partnership to test new technologies in real-world care
September 10, 2026
